Are MicroRNAs Key to Developing Biomarkers for Cutaneous T-Cell Lymphoma?

J Invest Dermatol. 2018 Sep;138(9):1906-1908. doi: 10.1016/j.jid.2018.04.012.

Abstract

MicroRNAs are noncoding molecules that induce epigenetic modulation, and they have been involved in tumorigenesis of solid and hematologic malignancies, including cutaneous T-cell lymphoma. MicroRNAs appear to play a role in cutaneous T-cell lymphoma pathogenesis and in disease progression. We comment on recent efforts to develop microRNA classifiers that improve cutaneous T-cell lymphoma diagnosis and predict disease course.

Publication types

  • Comment

MeSH terms

  • Biomarkers
  • Cell Transformation, Neoplastic
  • Humans
  • Lymphoma, T-Cell, Cutaneous*
  • MicroRNAs*
  • Prognosis

Substances

  • Biomarkers
  • MicroRNAs